Nevertheless, we cannot exclude dysregulation of vesicle trafficking due to lack of dystrophin as a possible source of cytosolic/cytoskeletal proteins in DMD patient serum (44). This evidence concerns the gene DNM2 and Duchenne muscular dystrophy.